What is Balchem Corp's earnings per share (EPS)?

Balchem Corp (BCPC) reported diluted earnings per share of $4.75 for fiscal year 2025. This represents a 20.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Balchem Corp Financials

BCPC

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Balchem Corp (BCPC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 57/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Balchem Corp has an operating margin of 20.2%, meaning the company retains $20 of operating profit per $100 of revenue. This strong profitability earns a score of 67/100, reflecting efficient cost management and pricing power. This is up from 19.2% the prior year.

Growth

Balchem Corp's revenue grew 8.8% year-over-year to $1.0B, a solid pace of expansion. This earns a growth score of 48/100.

Leverage

Balchem Corp carries a low D/E ratio of 0.34, meaning only $0.34 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 95/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Balchem Corp's current ratio of 2.07 indicates adequate short-term liquidity, earning a score of 38/100. The company can meet its near-term obligations, though with limited headroom.

Returns

Balchem Corp's ROE of 12.3% shows moderate profitability relative to equity, earning a score of 38/100. This is up from 11.2% the prior year.

Altman Z-Score Safe

9.71

Balchem Corp scores 9.71, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($5.4B) relative to total liabilities ($428.8M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Strong

8/9

Balchem Corp passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.40x

For every $1 of reported earnings, Balchem Corp generates $1.40 in operating cash flow ($216.6M OCF vs $154.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.0B

YoY+8.8%

5Y CAGR+8.1%

10Y CAGR+6.5%

Balchem Corp generated $1.0B in revenue in fiscal year 2025. This represents an increase of 8.8% from the prior year.

EBITDA

$255.0M

YoY+10.5%

5Y CAGR+9.4%

10Y CAGR+6.7%

Balchem Corp's EBITDA was $255.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 10.5% from the prior year.

Net Income

$154.8M

YoY+20.5%

5Y CAGR+12.8%

10Y CAGR+10.0%

Balchem Corp reported $154.8M in net income in fiscal year 2025. This represents an increase of 20.5% from the prior year.

EPS (Diluted)

$4.75

YoY+20.9%

5Y CAGR+12.8%

10Y CAGR+9.7%

Balchem Corp earned $4.75 per diluted share (EPS) in fiscal year 2025. This represents an increase of 20.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$74.6M

YoY+50.6%

5Y CAGR-2.5%

10Y CAGR-1.3%

Balchem Corp held $74.6M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.96

YoY+10.3%

Balchem Corp paid $0.96 per share in dividends in fiscal year 2025. This represents an increase of 10.3% from the prior year.

Shares Outstanding

32M

YoY-1.6%

5Y CAGR-0.2%

10Y CAGR+0.2%

Balchem Corp had 32M shares outstanding in fiscal year 2025. This represents a decrease of 1.6% from the prior year.

Margins & Returns

Gross Margin

35.7%

YoY+0.5pp

5Y CAGR+3.9pp

10Y CAGR+5.3pp

Balchem Corp's gross margin was 35.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.5 percentage points from the prior year.

Operating Margin

20.2%

YoY+1.0pp

5Y CAGR+4.4pp

10Y CAGR+3.2pp

Balchem Corp's operating margin was 20.2% in fiscal year 2025, reflecting core business profitability. This is up 1.0 percentage points from the prior year.

Net Margin

14.9%

YoY+1.5pp

5Y CAGR+2.9pp

10Y CAGR+4.1pp

Balchem Corp's net profit margin was 14.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.5 percentage points from the prior year.

Return on Equity

12.3%

YoY+1.1pp

5Y CAGR+2.1pp

10Y CAGR-0.6pp

Balchem Corp's ROE was 12.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.1 percentage points from the prior year.

Capital Allocation

R&D Spending

$18.5M

YoY+10.2%

5Y CAGR+12.4%

10Y CAGR+11.9%

Balchem Corp invested $18.5M in research and development in fiscal year 2025. This represents an increase of 10.2% from the prior year.

Share Buybacks

$107.6M

YoY+1794.3%

5Y CAGR+51.6%

10Y CAGR+56.7%

Balchem Corp spent $107.6M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 1794.3% from the prior year.

Capital Expenditures

N/A

BCPC Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.0B+8.8%	$953.7M+3.4%	$922.4M-2.1%	$942.4M+17.9%	$799.0M+13.6%	$703.6M
Cost of Revenue	$666.5M+7.9%	$617.5M-0.5%	$620.4M-6.3%	$661.9M+19.1%	$555.8M+15.9%	$479.7M
Gross Profit	$370.6M+10.2%	$336.2M+11.3%	$302.1M+7.7%	$280.5M+15.3%	$243.2M+8.6%	$223.9M
R&D Expenses	$18.5M+10.2%	$16.8M+11.6%	$15.0M+23.4%	$12.2M-9.9%	$13.5M+30.9%	$10.3M
SG&A Expenses	$67.4M-0.2%	$67.6M+26.5%	$53.4M-4.0%	$55.7M+33.4%	$41.7M-4.7%	$43.8M
Operating Income	$209.3M+14.4%	$182.9M+14.9%	$159.2M+9.6%	$145.2M+13.9%	$127.5M+14.7%	$111.1M
Interest Expense	N/A	N/A	-$22.6M-120.2%	-$10.3M-318.1%	-$2.5M+44.7%	-$4.4M
Income Tax	$44.2M+16.3%	$38.0M+32.2%	$28.7M+1.2%	$28.4M-2.6%	$29.1M+33.7%	$21.8M
Net Income	$154.8M+20.5%	$128.5M+18.4%	$108.5M+3.0%	$105.4M+9.6%	$96.1M+13.6%	$84.6M
EPS (Diluted)	$4.75+20.9%	$3.93+17.3%	$3.35+3.1%	$3.25+10.5%	$2.94+13.1%	$2.60

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$263.6M-1.5%	$267.6M+4.7%	$255.5M+2.0%	$250.5M+4.4%	$240.0M0.0%	$239.9M+2.5%	$234.1M-2.3%	$239.7M
Cost of Revenue	N/A	$172.1M+6.0%	$162.4M0.0%	$162.4M	N/A	$154.6M+2.3%	$151.1M-4.5%	$158.1M
Gross Profit	$93.9M-1.6%	$95.5M+2.5%	$93.1M+5.6%	$88.2M+2.1%	$86.3M+1.1%	$85.4M+2.9%	$83.0M+1.8%	$81.5M
R&D Expenses	N/A	$4.5M+4.6%	$4.3M-7.8%	$4.7M	N/A	$4.3M+12.3%	$3.9M-6.0%	$4.1M
SG&A Expenses	N/A	$17.3M-4.3%	$18.1M+16.1%	$15.6M	N/A	$17.5M+14.1%	$15.3M-12.5%	$17.5M
Operating Income	N/A	$54.6M+6.1%	$51.4M+0.8%	$51.0M	N/A	$48.0M+4.8%	$45.8M+9.9%	$41.7M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$5.4M
Income Tax	N/A	$11.8M+9.5%	$10.7M-1.4%	$10.9M	N/A	$10.1M+9.8%	$9.2M+16.4%	$7.9M
Net Income	$39.2M-2.6%	$40.3M+5.3%	$38.3M+3.3%	$37.1M+10.3%	$33.6M-0.8%	$33.8M+5.5%	$32.1M+10.6%	$29.0M
EPS (Diluted)	$1.21-2.4%	$1.24+6.0%	$1.17+3.5%	$1.13+9.7%	$1.030.0%	$1.03+5.1%	$0.98+10.1%	$0.89

BCPC Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$1.7B+7.0%	$1.6B-1.4%	$1.6B-1.7%	$1.6B+35.5%	$1.2B+2.9%	$1.2B
Current Assets	$365.6M+16.5%	$313.8M-0.2%	$314.2M-6.4%	$335.8M+4.2%	$322.2M+20.7%	$266.9M
Cash & Equivalents	$74.6M+50.6%	$49.5M-23.2%	$64.4M-3.2%	$66.6M-35.5%	$103.2M+22.1%	$84.6M
Inventory	$131.4M+0.5%	$130.8M+19.4%	$109.5M-8.5%	$119.7M+31.4%	$91.1M+28.9%	$70.6M
Accounts Receivable	$143.6M+20.0%	$119.7M-4.5%	$125.3M-4.8%	$131.6M+12.1%	$117.4M+19.5%	$98.2M
Goodwill	$816.4M+4.7%	$780.0M+0.1%	$778.9M+1.2%	$769.5M+46.9%	$523.9M-1.0%	$529.5M
Total Liabilities	$428.8M+0.8%	$425.5M-21.7%	$543.2M-20.8%	$686.2M+112.9%	$322.3M-4.5%	$337.6M
Current Liabilities	$176.4M+11.9%	$157.7M+6.2%	$148.5M+6.0%	$140.0M-2.6%	$143.8M+52.3%	$94.4M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.3B+9.3%	$1.1B+9.1%	$1.1B+12.3%	$938.3M+7.0%	$877.0M+5.9%	$828.2M
Retained Earnings	$1.1B+12.4%	$997.5M+11.1%	$897.5M+10.2%	$814.5M+11.2%	$732.1M+11.5%	$656.7M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$1.7B+1.5%	$1.7B-1.0%	$1.7B+3.8%	$1.6B+2.7%	$1.6B-1.4%	$1.6B+1.4%	$1.6B-0.9%	$1.6B
Current Assets	$365.6M+6.4%	$343.7M-5.8%	$364.9M+7.2%	$340.2M+8.4%	$313.8M-3.7%	$326.0M+1.8%	$320.2M-1.4%	$324.9M
Cash & Equivalents	$74.6M+14.6%	$65.1M-0.5%	$65.4M+31.1%	$49.9M+0.8%	$49.5M-32.8%	$73.7M+15.6%	$63.7M+5.6%	$60.3M
Inventory	$131.4M-0.7%	$132.4M-10.6%	$148.2M+2.2%	$144.9M+10.8%	$130.8M+10.4%	$118.5M+1.2%	$117.1M+6.1%	$110.4M
Accounts Receivable	$143.6M+9.2%	$131.5M-3.3%	$136.0M+4.2%	$130.4M+9.0%	$119.7M-0.7%	$120.5M-2.3%	$123.4M-11.8%	$139.9M
Goodwill	$816.4M0.0%	$816.5M0.0%	$816.4M+2.9%	$793.1M+1.7%	$780.0M-0.1%	$781.1M+1.4%	$770.0M-0.2%	$771.5M
Total Liabilities	$428.8M+18.1%	$363.2M-11.5%	$410.3M+0.4%	$408.9M-3.9%	$425.5M+1.4%	$419.7M-9.3%	$462.6M-9.3%	$509.9M
Current Liabilities	$176.4M+39.6%	$126.4M-8.5%	$138.1M-1.0%	$139.6M-11.5%	$157.7M+44.1%	$109.4M-3.4%	$113.3M-8.9%	$124.4M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.3B-3.1%	$1.3B+2.4%	$1.3B+4.9%	$1.2B+5.1%	$1.1B-2.3%	$1.2B+5.8%	$1.1B+3.1%	$1.1B
Retained Earnings	$1.1B+0.7%	$1.1B+3.8%	$1.1B+3.7%	$1.0B+3.7%	$997.5M+0.5%	$992.4M+3.5%	$958.5M+3.5%	$926.5M

BCPC Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$216.6M+19.0%	$182.0M-1.0%	$183.8M+32.6%	$138.5M-13.7%	$160.5M+6.7%	$150.5M
Capital Expenditures	N/A	N/A	N/A	$49.1M+35.8%	$36.1M+12.7%	$32.1M
Free Cash Flow	N/A	N/A	N/A	$89.5M-28.1%	$124.4M+5.0%	$118.4M
Investing Cash Flow	-$43.9M+26.5%	-$59.7M-71.6%	-$34.8M+91.6%	-$416.0M-1078.5%	-$35.3M-2.0%	-$34.6M
Financing Cash Flow	-$152.8M-14.2%	-$133.8M+12.7%	-$153.3M-162.2%	$246.7M+341.4%	-$102.2M-1.0%	-$101.2M
Dividends Paid	$28.3M+10.6%	$25.6M+11.8%	$22.9M+10.4%	$20.7M+10.6%	$18.7M+12.1%	$16.7M
Share Buybacks	$107.6M+1794.3%	$5.7M+27.1%	$4.5M-87.4%	$35.4M+0.5%	$35.2M+161.7%	$13.5M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$67.3M+2.6%	$65.6M+38.8%	$47.3M+29.6%	$36.5M-30.3%	$52.3M+2.0%	$51.3M+14.0%	$45.0M+34.8%	$33.4M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$16.4M-9.9%	-$14.9M-125.7%	-$6.6M-12.0%	-$5.9M+84.0%	-$37.0M-302.6%	-$9.2M-33.9%	-$6.9M-1.8%	-$6.7M
Financing Cash Flow	-$41.2M+18.9%	-$50.8M-76.7%	-$28.8M+10.0%	-$32.0M+9.2%	-$35.2M-2.4%	-$34.4M-0.6%	-$34.2M-13.9%	-$30.0M
Dividends Paid	$11K0.0%	$11K+450.0%	$2K-100.0%	$28.3M+706475.0%	$4K0.0%	$4K-69.2%	$13K-99.9%	$25.6M
Share Buybacks	$53.6M+247.8%	$15.4M-53.6%	$33.3M+524.7%	$5.3M+1640.2%	$306K+87.7%	$163K+1381.8%	$11K-99.8%	$5.2M

BCPC Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	35.7%+0.5pp	35.3%+2.5pp	32.8%+3.0pp	29.8%-0.7pp	30.4%-1.4pp	31.8%
Operating Margin	20.2%+1.0pp	19.2%+1.9pp	17.3%+1.9pp	15.4%-0.6pp	16.0%+0.2pp	15.8%
Net Margin	14.9%+1.5pp	13.5%+1.7pp	11.8%+0.6pp	11.2%-0.9pp	12.0%0.0pp	12.0%
Return on Equity	12.3%+1.1pp	11.2%+0.9pp	10.3%-0.9pp	11.2%+0.3pp	11.0%+0.7pp	10.2%
Return on Assets	9.2%+1.0pp	8.2%+1.4pp	6.8%+0.3pp	6.5%-1.5pp	8.0%+0.8pp	7.3%
Current Ratio	2.07+0.1	1.99-0.1	2.12-0.3	2.40+0.2	2.24-0.6	2.83
Debt-to-Equity	0.34-0.0	0.37-0.1	0.52-0.2	0.73+0.4	0.37-0.0	0.41
FCF Margin	N/A	N/A	N/A	9.5%-6.1pp	15.6%-1.3pp	16.8%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	35.6%-0.1pp	35.7%-0.8pp	36.4%+1.3pp	35.2%-0.8pp	36.0%+0.4pp	35.6%+0.1pp	35.5%+1.5pp	34.0%
Operating Margin	N/A	20.4%+0.3pp	20.1%-0.2pp	20.4%	N/A	20.0%+0.4pp	19.6%+2.2pp	17.4%
Net Margin	14.9%-0.2pp	15.1%+0.1pp	15.0%+0.2pp	14.8%+0.8pp	14.0%-0.1pp	14.1%+0.4pp	13.7%+1.6pp	12.1%
Return on Equity	3.1%+0.0pp	3.1%+0.1pp	3.0%-0.1pp	3.1%+0.2pp	2.9%+0.1pp	2.9%0.0pp	2.9%+0.2pp	2.7%
Return on Assets	2.3%-0.1pp	2.4%+0.1pp	2.3%0.0pp	2.3%+0.2pp	2.1%0.0pp	2.1%+0.1pp	2.0%+0.2pp	1.8%
Current Ratio	2.07-0.6	2.72+0.1	2.64+0.2	2.44+0.4	1.99-1.0	2.98+0.2	2.83+0.2	2.61
Debt-to-Equity	0.34+0.1	0.28-0.0	0.32-0.0	0.34-0.0	0.37+0.0	0.36-0.1	0.42-0.1	0.47
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Sensient Tech SXT

$3.9B

Cabot CBT

$3.9B

Element Solutions Inc ESI

$8.4B

Sasol SSL

$8.7B

Axalta Coating Sys Ltd AXTA

$5.6B

Frequently Asked Questions

What is Balchem Corp's annual revenue?

Balchem Corp (BCPC) reported $1.0B in total revenue for fiscal year 2025. This represents a 8.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Balchem Corp's revenue growing?

Balchem Corp (BCPC) revenue grew by 8.8% year-over-year, from $953.7M to $1.0B in fiscal year 2025.

Is Balchem Corp profitable?

Yes, Balchem Corp (BCPC) reported a net income of $154.8M in fiscal year 2025, with a net profit margin of 14.9%.

What is Balchem Corp's EBITDA?

Balchem Corp (BCPC) had EBITDA of $255.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Balchem Corp's gross margin?

Balchem Corp (BCPC) had a gross margin of 35.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Balchem Corp's operating margin?

Balchem Corp (BCPC) had an operating margin of 20.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Balchem Corp's net profit margin?

Balchem Corp (BCPC) had a net profit margin of 14.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Balchem Corp pay dividends?

Yes, Balchem Corp (BCPC) paid $0.96 per share in dividends during fiscal year 2025.

What is Balchem Corp's return on equity (ROE)?

Balchem Corp (BCPC) has a return on equity of 12.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Balchem Corp's operating cash flow?

Balchem Corp (BCPC) generated $216.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Balchem Corp's total assets?

Balchem Corp (BCPC) had $1.7B in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Balchem Corp spend on research and development?

Balchem Corp (BCPC) invested $18.5M in research and development during fiscal year 2025.

Does Balchem Corp buy back shares?

Yes, Balchem Corp (BCPC) spent $107.6M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Balchem Corp have outstanding?

Balchem Corp (BCPC) had 32M shares outstanding as of fiscal year 2025.

What is Balchem Corp's current ratio?

Balchem Corp (BCPC) had a current ratio of 2.07 as of fiscal year 2025, which is generally considered healthy.

What is Balchem Corp's debt-to-equity ratio?

Balchem Corp (BCPC) had a debt-to-equity ratio of 0.34 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Balchem Corp's return on assets (ROA)?

Balchem Corp (BCPC) had a return on assets of 9.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Balchem Corp's Altman Z-Score?

Balchem Corp (BCPC) has an Altman Z-Score of 9.71, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Balchem Corp's Piotroski F-Score?

Balchem Corp (BCPC) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Balchem Corp's earnings high quality?

Balchem Corp (BCPC) has an earnings quality ratio of 1.40x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Balchem Corp?

Balchem Corp (BCPC) scores 57 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.